The Week in Review: September 15 – September 22, 2017

Friday, September 22, 2017 News Recap: Access to Treatment: This was a good week in terms of treatment access (but not, unfortunately, in terms of weather or seismic activity: How very, very sad).  Imagine being sick or on treatment in one of these stricken areas! In Canada Epclusa was approved for use in persons co-infected with HIV. This is very good news. Gilead Receives Approval in Canada for Expanded Indication of EPCLUSA® (Sofosbuvir/Velpat...

The Financial Burden of Liver Disease

Liver disease is a common cause of premature death in the UK. Recently, The Lancet Commission on Liver Disease highlighted the financial impact liver disease places on the national healthcare system and businesses, and suggested strategies to reduce these burdens. The negative impacts of liver disease on citizens under the age of 65 in the UK are escalating, particularly in those from low socioeconomic backgrounds. This can be reversed by targeting the th